Antibody production can slow research to a crawl. As senior vice president of Biointron, Lei Shi works with scientists around the globe to optimize and expedite their antibody projects, from start to ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
You don't want to miss this! To permanently access this Infographic for free, fill out the short form below. Looking to sidestep common challenges in therapeutic antibody production, such as low ...
Efficient production of monoclonal antibodies (mAb) using Chinese Hamster Ovary (CHO) cells is central to pharmaceutical biomanufacturing. The clone selection process traditionally requires lengthy ...
Molecular biology's central dogma posits a simple recipe for the construction of the human body: a DNA blueprint is transcribed into an RNA message, and the RNA message is translated into the proteins ...
Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the Center for Human Immunobiology, have discovered how critical IgA antibodies ...
Antibody production companies are essential in dealing with the growing demand for antibodies for life sciences, therapeutic, and diagnostic applications. Therefore, a number of service providers are ...
As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...
The antibody therapeutics industry is growing at an incredible pace. From early monoclonal therapeutic antibodies to modern bispecific and multispecific antibodies, single domain antibodies (VHHs), ...
Antibody conjugates play a central role across multiple healthcare sectors with a prime example being antibody-drug conjugates (ADCs). Although widely used lysine and hinge cysteine conjugation ...
Biointron Launches RushData, an Integrated High-Throughput Platform for AI-Driven Antibody Discovery
RushData is a newly launched platform that accelerates antibody data generation from weeks to days through 1-day CHO expression and high-throughput, parallel processing of 3,000+ molecules per batch, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results